Want to see AUPH full AI Analyst Report?
Aurinia Pharmaceuticals (AUPH) Ownership Overview
12.80% Insiders
4.56% Mutual Funds
19.50% Other Institutional Investors
7.20% ETFs
55.94% Public Companies and
Individual Investors
The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 31.26% of the company’s stock is owned by Institutional Investors, 12.80% is owned by Insiders, and 55.94% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 02, 2026 | xxxxxxxxxxxxx | $12455227 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,044,106 | Insider | 9.80% | 212,488,487 | |
| 5,704,837 | Institution | 4.29% | 92,931,795 | |
| 1,864,706 | Institution | 1.40% | 30,376,061 | |
| 1,744,866 | Insider | 1.31% | 28,423,867 | |
| 1,285,783 | Institution | 0.97% | 20,945,405 | |
| 1,269,557 | Institution | 0.95% | 20,681,084 | |
| 710,464 | Institution | 0.53% | 11,573,459 | |
| 662,900 | Insider | 0.50% | 10,798,641 | |
| 600,787 | Insider | 0.45% | 9,786,820 | |
| 556,703 | Insider | 0.42% | 9,068,692 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,864,706 | Institution | 1.40% | 30,376,061 | |
| 1,269,557 | Institution | 0.95% | 20,681,084 | |
| 710,464 | Institution | 0.53% | 11,573,459 | |
| 431,177 | Institution | 0.32% | 7,023,873 | |
| 336,741 | Institution | 0.25% | 5,485,511 | |
| 172,372 | Institution | 0.13% | 2,807,940 | |
| 111,924 | Institution | 0.08% | 1,823,242 | |
| 92,212 | Institution | 0.07% | 1,502,133 | |
| 84,000 | Institution | 0.06% | 1,368,360 | |
| 80,526 | Institution | 0.06% | 1,311,769 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,031,046 | Institution | 2.28% | 49,375,739 | |
| 1,103,469 | Institution | 0.83% | 17,975,510 | |
| 847,596 | Institution | 0.64% | 13,807,339 | |
| 669,171 | Institution | 0.50% | 9,957,264 | |
| 440,602 | Institution | 0.33% | 7,071,662 | |
| 322,514 | Institution | 0.24% | 4,799,008 | |
| 233,800 | Institution | 0.18% | 3,752,490 | |
| 226,583 | Institution | 0.17% | 3,636,657 | |
| 180,771 | Institution | 0.14% | 2,901,375 | |
| 128,900 | Institution | 0.10% | 1,918,032 |
FAQ
Who Owns Aurinia Pharmaceuticals (AUPH)?
According to the latest TipRanks data, approximately 19.50% of the company's stock is held by institutional investors, 12.80% is held by insiders, and 55.94% is held by retail investors.
What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.50% of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors.
What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors?
According to the latest TipRanks data, approximately 55.94% of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors.
Who owns the most shares of Aurinia Pharmaceuticals (AUPH)?
Kevin Tang owns the most shares of Aurinia Pharmaceuticals (AUPH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.